TY - JOUR
T1 - Helminth-induced arginase-1 exacerbates lung inflammation and disease severity in tuberculosis
AU - Monin, Leticia
AU - Griffiths, Kristin L.
AU - Lam, Wing Y.
AU - Gopal, Radha
AU - Kang, Dongwan D.
AU - Ahmed, Mushtaq
AU - Rajamanickam, Anuradha
AU - Cruz-Lagunas, Alfredo
AU - Zúñiga, Joaquín
AU - Babu, Subash
AU - Kolls, Jay K.
AU - Mitreva, Makedonka
AU - Rosa, Bruce A.
AU - Ramos-Payan, Rosalio
AU - Morrison, Thomas E.
AU - Murray, Peter J.
AU - Rangel-Moreno, Javier
AU - Pearce, Edward J.
AU - Khader, Shabaana A.
PY - 2015/12
Y1 - 2015/12
N2 - Parasitic helminth worms, such as Schistosoma mansoni, are endemic in regions with a high prevalence of tuberculosis (TB) among the population. Human studies suggest that helminth coinfections contribute to increased TB susceptibility and increased rates of TB reactivation. Prevailing models suggest that T helper type 2 (Th2) responses induced by helminth infection impair Th1 immune responses and thereby limit Mycobacterium tuberculosis (Mtb) control. Using a pulmonary mouse model of Mtb infection, we demonstrated that S. mansoni coinfection or immunization with S. mansoni egg antigens can reversibly impair Mtb-specific T cell responses without affecting macrophage-mediated Mtb control. Instead, S. mansoni infection resulted in accumulation of high arginase-1-expressing macrophages in the lung, which formed type 2 granulomas and exacerbated inflammation in Mtb-infected mice. Treatment of coinfected animals with an antihelminthic improved Mtb-specific Th1 responses and reduced disease severity. In a genetically diverse mouse population infected with Mtb, enhanced arginase-1 activity was associated with increased lung inflammation. Moreover, in patients with pulmonary TB, lung damage correlated with increased serum activity of arginase-1, which was elevated in TB patients coinfected with helminths. Together, our data indicate that helminth coinfection induces arginase-1-expressing type 2 granulomas, thereby increasing inflammation and TB disease severity. These results also provide insight into the mechanisms by which helminth coinfections drive increased susceptibility, disease progression, and severity in TB.
AB - Parasitic helminth worms, such as Schistosoma mansoni, are endemic in regions with a high prevalence of tuberculosis (TB) among the population. Human studies suggest that helminth coinfections contribute to increased TB susceptibility and increased rates of TB reactivation. Prevailing models suggest that T helper type 2 (Th2) responses induced by helminth infection impair Th1 immune responses and thereby limit Mycobacterium tuberculosis (Mtb) control. Using a pulmonary mouse model of Mtb infection, we demonstrated that S. mansoni coinfection or immunization with S. mansoni egg antigens can reversibly impair Mtb-specific T cell responses without affecting macrophage-mediated Mtb control. Instead, S. mansoni infection resulted in accumulation of high arginase-1-expressing macrophages in the lung, which formed type 2 granulomas and exacerbated inflammation in Mtb-infected mice. Treatment of coinfected animals with an antihelminthic improved Mtb-specific Th1 responses and reduced disease severity. In a genetically diverse mouse population infected with Mtb, enhanced arginase-1 activity was associated with increased lung inflammation. Moreover, in patients with pulmonary TB, lung damage correlated with increased serum activity of arginase-1, which was elevated in TB patients coinfected with helminths. Together, our data indicate that helminth coinfection induces arginase-1-expressing type 2 granulomas, thereby increasing inflammation and TB disease severity. These results also provide insight into the mechanisms by which helminth coinfections drive increased susceptibility, disease progression, and severity in TB.
UR - http://www.scopus.com/inward/record.url?scp=84948799387&partnerID=8YFLogxK
U2 - 10.1172/JCI77378
DO - 10.1172/JCI77378
M3 - Article
C2 - 26571397
AN - SCOPUS:84948799387
SN - 0021-9738
VL - 125
SP - 4699
EP - 4713
JO - Journal of Clinical Investigation
JF - Journal of Clinical Investigation
IS - 12
ER -